PARAMETERS OF INTERFERON ACTION .1. IMMUNOLOGICAL EFFECTS OF WHOLE CELL LEUKOCYTE INTERFERON (IFN-ALPHA) IN PHASE-I-II TRIALS

被引：0
|
作者：
ERNSTOFF, MS [1 ]
FUSI, S [1 ]
KIRKWOOD, JM [1 ]
机构：
[1] YALE UNIV,SCH MED,PLAST SURG SECT,NEW HAVEN,CT 06510
来源：
JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 1983年 / 2卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：528 / 539
页数：12
相关论文
共 50 条
  • [11] INTERFERON-ALPHA-2B PLUS FLOXURIDINE IN METASTATIC RENAL-CELL CARCINOMA - A PHASE-I-II STUDY
    FALCONE, A
    CIANCI, C
    RICCI, S
    BRUNETTI, I
    BERTUCCELLI, M
    CONTE, PF
    CANCER, 1993, 72 (02) : 564 - 568
  • [12] A PHASE-I-II TRIAL OF THE COMBINATION OF RECOMBINANT LEUKOCYTE-A INTERFERON AND RECOMBINANT HUMAN INTERFERON-GAMMA IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    CREAGAN, ET
    LOPRINZI, CL
    AHMANN, DL
    SCHAID, DJ
    CANCER, 1988, 62 (12) : 2472 - 2474
  • [13] PHASE-I-II TRIAL OF ZIDOVUDINE COMBINED WITH LYMPHOBLASTOID INTERFERON-ALPHA IN PATIENTS WITH AIDS AND KAPOSIS SARCOMA
    DEYTON, L
    KOVACS, JA
    MASUR, H
    METCALF, JA
    LEE, D
    SALZMAN, N
    BASELER, M
    BIGELY, J
    LANE, HC
    FAUCI, AS
    CLINICAL RESEARCH, 1988, 36 (03): : A438 - A438
  • [14] PARAMETERS OF INTERFERON ACTION-II - ENDOCRINE EFFECTS OBSERVED DURING TREATMENT OF MELANOMA PATIENTS WITH HUMAN-LEUKOCYTE INTERFERON
    KIRKWOOD, JM
    KAYNE, R
    AMARANTE, S
    CLINICAL RESEARCH, 1982, 30 (02): : A419 - A419
  • [15] PHASE-I-II STUDY OF MISMATCHED DOUBLE-STRANDED-RNA (AMPLIGEN) IN COMBINATION WITH INTERFERON-ALPHA-(LE)
    STRAYER, DR
    CARTER, WA
    CRILLEY, P
    NOVAK, S
    BRODSKY, I
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 382 - 382
  • [16] PHASE-I-II TRIAL OF INTERFERON-ALPHA-2B BY CONTINUOUS SUBCUTANEOUS INFUSION OVER 28 DAYS
    DORR, RT
    SALMON, SE
    ROBERTONE, A
    BONNEM, E
    JOURNAL OF INTERFERON RESEARCH, 1988, 8 (06): : 717 - 725
  • [17] HUMAN IMMUNE INTERFERON (IFN-GAMMA) AND LEUKOCYTE INTERFERON (IFN-ALPHA) DIVERT GRANULOCYTE-MACROPHAGE COLONY-FORMING CELL (GM-CFC) DIFFERENTIATION TO MONOCYTE-MACROPHAGES AND NOT TO GRANULOCYTES
    VERMA, DS
    JAGGANNATH, S
    GUTTERMAN, JU
    EXPERIMENTAL HEMATOLOGY, 1984, 12 (06) : 370 - 370
  • [18] IMMUNOLOGICAL ASSESSMENT OF MELANOMA PATIENTS TREATED WITH RECOMBINANT INTERFERON-GAMMA (R IFN-GAMMA, BIOGEN-INC, CAMBRIDGE, MA) IN A PHASE-I-II TRIAL
    ERNSTOFF, MS
    REICH, S
    NISHODA, Y
    KIRKWOOD, JM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 280 - 280
  • [19] PARAMETERS OF INTERFERON ACTION - T-CELL SUBSETS AND NK FUNCTION DURING A PHASE-I TRIAL OF RECOMBINANT HUMAN INTERFERON ALPHA-2
    FUSI, S
    HEBERT, CZ
    ARIYAN, S
    ERNSTOFF, M
    KIRKWOOD, JM
    CLINICAL RESEARCH, 1982, 30 (03): : A694 - A694
  • [20] HUMAN LYMPHOBLASTOID INTERFERON (IFN-ALPHA-N1) PLUS DOXORUBICIN, CYCLOPHOSPHAMIDE, AND CISPLATIN IN THE TREATMENT OF ADVANCED EPITHELIAL OVARIAN MALIGNANCIES - A PHASE-I-II STUDY OF THE GYNECOLOGIC ONCOLOGY GROUP
    DISAIA, PJ
    GILLETTE, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (01): : 71 - 74
12345